2024 Q2 Form 10-Q Financial Statement

#000010198424000068 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $90.45M $91.90M
YoY Change -15.77% -15.2%
Cost Of Revenue $64.50M $65.91M
YoY Change -22.08% -21.24%
Gross Profit $25.95M $25.99M
YoY Change 5.42% 5.24%
Gross Profit Margin 28.69% 28.28%
Selling, General & Admin $21.33M $24.01M
YoY Change -15.57% -10.35%
% of Gross Profit 82.19% 92.39%
Research & Development $7.520M $7.821M
YoY Change -11.36% -6.45%
% of Gross Profit 28.98% 30.09%
Depreciation & Amortization $3.300M $4.668M
YoY Change -45.14% -17.99%
% of Gross Profit 12.72% 17.96%
Operating Expenses $28.85M $31.83M
YoY Change -14.52% -9.42%
Operating Profit -$4.453M -$6.908M
YoY Change -51.24% -88.39%
Interest Expense -$843.0K -$922.0K
YoY Change -54.23% -5.44%
% of Operating Profit
Other Income/Expense, Net -$89.00K -$80.00K
YoY Change -306.98% -62.62%
Pretax Income -$5.385M -$7.910M
YoY Change -50.74% -86.97%
Income Tax $2.800M $700.0K
% Of Pretax Income
Net Earnings -$8.193M -$8.649M
YoY Change -21.3% -85.91%
Net Earnings / Revenue -9.06% -9.41%
Basic Earnings Per Share -$0.63 -$0.67
Diluted Earnings Per Share -$0.63 -$0.67
COMMON SHARES
Basic Shares Outstanding 12.89M shares 12.97M shares
Diluted Shares Outstanding 12.92M shares 12.90M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.13M $26.91M
YoY Change -58.57% -52.7%
Cash & Equivalents $23.13M $26.91M
Short-Term Investments
Other Short-Term Assets $11.13M $11.76M
YoY Change 94.21% 71.38%
Inventory $87.49M $83.24M
Prepaid Expenses
Receivables $93.11M $92.63M
Other Receivables $5.691M $6.854M
Total Short-Term Assets $226.1M $230.2M
YoY Change -19.45% -23.86%
LONG-TERM ASSETS
Property, Plant & Equipment $39.26M $42.14M
YoY Change -50.02% -31.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.404M $1.469M
YoY Change -80.54% -25.24%
Total Long-Term Assets $87.87M $92.71M
YoY Change -20.99% -19.1%
TOTAL ASSETS
Total Short-Term Assets $226.1M $230.2M
Total Long-Term Assets $87.87M $92.71M
Total Assets $314.0M $322.9M
YoY Change -19.89% -22.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.52M $49.76M
YoY Change 16.0% -1.99%
Accrued Expenses $38.98M $42.14M
YoY Change -12.89% -9.07%
Deferred Revenue $4.017M $3.677M
YoY Change 83.26% 90.03%
Short-Term Debt $41.00M $46.00M
YoY Change -45.33% -45.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $141.0M $138.7M
YoY Change -19.06% -26.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $719.0K $725.0K
YoY Change -95.42% -6.93%
Total Long-Term Liabilities $719.0K $725.0K
YoY Change -95.42% -6.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $141.0M $138.7M
Total Long-Term Liabilities $719.0K $725.0K
Total Liabilities $154.2M $153.3M
YoY Change -19.65% -25.56%
SHAREHOLDERS EQUITY
Retained Earnings $215.6M $223.8M
YoY Change -16.73% -16.9%
Common Stock $341.0M $339.1M
YoY Change 2.62% 2.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $371.8M $371.2M
YoY Change 0.75% 0.6%
Treasury Stock Shares
Shareholders Equity $159.8M $169.7M
YoY Change
Total Liabilities & Shareholders Equity $314.0M $322.9M
YoY Change -19.89% -22.55%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$8.193M -$8.649M
YoY Change -21.3% -85.91%
Depreciation, Depletion And Amortization $3.300M $4.668M
YoY Change -45.14% -17.99%
Cash From Operating Activities $5.450M -$2.775M
YoY Change -64.33% 37.04%
INVESTING ACTIVITIES
Capital Expenditures $2.638M $1.347M
YoY Change -38.23% -58.69%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.638M -$2.366M
YoY Change -38.23% -51.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.611M -$10.23M
YoY Change -44.13% 168.36%
NET CHANGE
Cash From Operating Activities 5.450M -$2.775M
Cash From Investing Activities -2.638M -$2.366M
Cash From Financing Activities -5.611M -$10.23M
Net Change In Cash -2.799M -$15.84M
YoY Change -389.75% 61.04%
FREE CASH FLOW
Cash From Operating Activities $5.450M -$2.775M
Capital Expenditures $2.638M $1.347M
Free Cash Flow $2.812M -$4.122M
YoY Change -74.46% -22.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65912000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83684000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
25988000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
24693000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7821000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8360000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1064000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24011000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26782000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
49075000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6908000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-59524000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-922000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-975000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-214000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7910000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60713000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
739000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
650000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8649000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.81
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.81
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12902000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12749000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12902000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12749000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8649000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1591000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1916000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10240000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59447000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
178920000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1591000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
301000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1230000 usd
CY2024Q1 ueic Shares Issued To Directors Value
SharesIssuedToDirectorsValue
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1904000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
169655000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
268406000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1916000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
352000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
812000 usd
CY2023Q1 ueic Shares Issued To Directors Value
SharesIssuedToDirectorsValue
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2540000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211039000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8649000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4668000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5692000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
701000 usd
CY2024Q1 ueic Shares Issued For Employee Benefit Plan
SharesIssuedForEmployeeBenefitPlan
301000 usd
CY2023Q1 ueic Shares Issued For Employee Benefit Plan
SharesIssuedForEmployeeBenefitPlan
352000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1904000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2540000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
49075000 usd
CY2024Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
49000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-11007000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7723000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4132000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18056000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3051000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1408000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12517000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26051000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-567000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-208000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2775000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2025000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1347000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3261000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1019000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1570000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2366000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4831000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
24000000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
14000000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
33000000 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
17000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1230000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
812000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10230000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3812000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-466000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
834000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15837000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9834000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42751000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66740000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26914000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56906000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
777000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2065000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1368000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1413000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates and assumptions, including those related to revenue recognition; allowance for credit losses; inventory valuation; impairment of long-lived assets, intangible assets and goodwill; business combinations; income taxes and related valuation allowances and stock-based compensation expense. Actual results may differ from these assumptions and estimates, and they may be adjusted as more information becomes available. Any adjustment may be material.</span></div>
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26914000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42751000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108377000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108377000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
93840000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
106182000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
803000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
815000 usd
CY2024Q1 ueic Allowance For Sales Returns
AllowanceForSalesReturns
410000 usd
CY2023Q4 ueic Allowance For Sales Returns
AllowanceForSalesReturns
532000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92627000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104835000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6854000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7761000 usd
CY2024Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
99481000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
112596000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
815000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
957000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 usd
CY2024Q1 ueic Allowance For Doubtful Accounts Receivable Write Offs And Effect Of Exchange Rate
AllowanceForDoubtfulAccountsReceivableWriteOffsAndEffectOfExchangeRate
12000 usd
CY2023Q1 ueic Allowance For Doubtful Accounts Receivable Write Offs And Effect Of Exchange Rate
AllowanceForDoubtfulAccountsReceivableWriteOffsAndEffectOfExchangeRate
178000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
803000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
780000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3501000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1931000 usd
CY2024Q1 ueic Contract With Customer Liability Payments Received
ContractWithCustomerLiabilityPaymentsReceived
1837000 usd
CY2023Q1 ueic Contract With Customer Liability Payments Received
ContractWithCustomerLiabilityPaymentsReceived
1687000 usd
CY2024Q1 ueic Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
938000 usd
CY2023Q1 ueic Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
916000 usd
CY2024Q1 ueic Contract With Customer Liability Foreign Exchange Effects
ContractWithCustomerLiabilityForeignExchangeEffects
-16000 usd
CY2023Q1 ueic Contract With Customer Liability Foreign Exchange Effects
ContractWithCustomerLiabilityForeignExchangeEffects
0 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4384000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2702000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29476000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32794000 usd
CY2024Q1 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
10979000 usd
CY2023Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
11061000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3438000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3827000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
39343000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40591000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
83236000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
88273000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
59383000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
63312000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
165000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
163300000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
3400000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4600000 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
49100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
43693000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18561000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25132000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
46366000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21017000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25349000 usd
CY2024Q1 ueic Finite Lived Intangible Assets Fully Amortized Gross
FiniteLivedIntangibleAssetsFullyAmortizedGross
48500000 usd
CY2023Q4 ueic Finite Lived Intangible Assets Fully Amortized Gross
FiniteLivedIntangibleAssetsFullyAmortizedGross
45000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1236000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1065000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3920000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4677000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4030000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3219000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2591000 usd
CY2024Q1 ueic Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
6695000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25132000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
16006000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17239000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18693000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4529000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4813000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11477000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12560000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
16006000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17373000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1859000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1868000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1745000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1831000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0506
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0504
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4007000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4448000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3426000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2681000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1228000 usd
CY2024Q1 ueic Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2479000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18269000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2263000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
46000000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
55000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
6200000 usd
CY2024Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
1300000 usd
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
1400000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3400000 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1417000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2843000 usd
CY2024Q1 ueic Accrued Employee Sales Commission Current
AccruedEmployeeSalesCommissionCurrent
336000 usd
CY2023Q4 ueic Accrued Employee Sales Commission Current
AccruedEmployeeSalesCommissionCurrent
602000 usd
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4469000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4085000 usd
CY2024Q1 ueic Accrued Social Insurance Current
AccruedSocialInsuranceCurrent
6825000 usd
CY2023Q4 ueic Accrued Social Insurance Current
AccruedSocialInsuranceCurrent
7082000 usd
CY2024Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3320000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3252000 usd
CY2024Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2022000 usd
CY2023Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2441000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18389000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20305000 usd
CY2024Q1 ueic Accrued Severance Current
AccruedSeveranceCurrent
32000 usd
CY2023Q4 ueic Accrued Severance Current
AccruedSeveranceCurrent
100000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3677000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2697000 usd
CY2024Q1 ueic Accrued Duties Current
AccruedDutiesCurrent
542000 usd
CY2023Q4 ueic Accrued Duties Current
AccruedDutiesCurrent
481000 usd
CY2024Q1 ueic Accrued Expense Associated With Fulfilled Performance Obligations
AccruedExpenseAssociatedWithFulfilledPerformanceObligations
941000 usd
CY2023Q4 ueic Accrued Expense Associated With Fulfilled Performance Obligations
AccruedExpenseAssociatedWithFulfilledPerformanceObligations
1092000 usd
CY2024Q1 ueic Accrued Freight And Handling Fees Current
AccruedFreightAndHandlingFeesCurrent
1630000 usd
CY2023Q4 ueic Accrued Freight And Handling Fees Current
AccruedFreightAndHandlingFeesCurrent
1998000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
374000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
438000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4529000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4813000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
522000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
522000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1539000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1558000 usd
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2192000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4194000 usd
CY2024Q1 ueic Other Accrued Expenses Current
OtherAccruedExpensesCurrent
3783000 usd
CY2023Q4 ueic Other Accrued Expenses Current
OtherAccruedExpensesCurrent
3388000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19729000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21181000 usd
CY2024Q1 ueic Accrued Property Plant And Equipment Purchases
AccruedPropertyPlantAndEquipmentPurchases
400000 usd
CY2023Q4 ueic Accrued Property Plant And Equipment Purchases
AccruedPropertyPlantAndEquipmentPurchases
200000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
522000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
522000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
0 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
0 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
0 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
0 usd
CY2024Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
CY2023Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
522000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
522000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
462000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1064000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
1330000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
196000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
5079000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
934000 usd
CY2024Q1 ueic Number Of Inter Partes Review Ipr Requests Denied
NumberOfInterPartesReviewIPRRequestsDenied
14 inter_partes_review
CY2024Q1 ueic Number Of Inter Partes Review Ipr Requests Granted
NumberOfInterPartesReviewIPRRequestsGranted
12 inter_partes_review
CY2024Q1 ueic Number Of Patents Subject To Inter Partes Review Ipr
NumberOfPatentsSubjectToInterPartesReviewIPR
2 patent
CY2024Q1 ueic Number Of Inter Partes Review Ipr Requests Granted
NumberOfInterPartesReviewIPRRequestsGranted
12 inter_partes_review
CY2021Q2 ueic Number Of Customers With A Filed Complaint
NumberOfCustomersWithAFiledComplaint
2 customer
CY2021Q2 ueic Number Of Customers With A Filed Complaint
NumberOfCustomersWithAFiledComplaint
2 customer
CY2024Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
35000000 cny
CY2024Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
35000000 cny
CY2024Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
4900000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
140000 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
53000 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1230000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
812000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1904000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2540000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
287000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
410000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.81
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
901000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.78
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
122000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
58.52
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
779000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.67
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M13D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
779000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.67
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y10M13D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
585000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.65
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M15D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-20000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-194000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-84000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-238000 usd
CY2024Q1 ueic Other Income Expense
OtherIncomeExpense
24000 usd
CY2023Q1 ueic Other Income Expense
OtherIncomeExpense
218000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-214000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8649000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12902000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12749000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.81
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8649000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-61363000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12902000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12749000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12902000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12749000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000101984-24-000068-index-headers.html Edgar Link pending
0000101984-24-000068-index.html Edgar Link pending
0000101984-24-000068.txt Edgar Link pending
0000101984-24-000068-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uei-03312024x10qxex311.htm Edgar Link pending
uei-03312024x10qxex312.htm Edgar Link pending
uei-03312024x10qxex32.htm Edgar Link pending
ueic-20240331.htm Edgar Link pending
ueic-20240331.xsd Edgar Link pending
ueic-20240331_cal.xml Edgar Link unprocessable
ueic-20240331_def.xml Edgar Link unprocessable
ueic-20240331_lab.xml Edgar Link unprocessable
ueic-20240331_pre.xml Edgar Link unprocessable
ueic-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable